Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Alopecia areata involves immune response and gene changes affecting hair loss.

Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Female hair loss can be diagnosed using specific trichoscopy criteria.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.